Insoluble problem?
D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*; D023582:Alzheimer Vaccines / Q000009:adverse effects* / Q000191:economics / Q000627:therapeutic use*; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D000818:Animals; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D006801:Humans
D023582:Alzheimer Vaccines; D016229:Amyloid beta-Peptides